MedTrace Logo

Laminaria and Misoprostol Before Operative Hysteroscopy

NCT03388827 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-12-07

No results posted yet for this study

Summary

Laminaria and Misoprostol before Operative Hysteroscopy

Conditions

  • Cervical Spasm

Interventions

DEVICE

Laminaria tent

Laminaria tent was inserted for 12 hours before Hysteroscopy

DRUG

Laminaria plus Misoprostol

Laminaria plus Misoprostol were inserted for 12 hours before Hysteroscopy

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2018-12-31
Completion
2019-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388827 on ClinicalTrials.gov